Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al

Area of Science:

• Endocrinology
• Cardiology
• Clinical Hypertension

Background:

• Hypertension is prevalent in acromegaly patients, affecting nearly half.
• Current blood pressure monitoring methods lack standardization, leading to inconsistent phenotype reporting.
• Variability in office, home, and ambulatory monitoring hinders accurate diagnosis and treatment guidance.

Purpose of the Study:

• To propose a standardized, risk-stratified approach for classifying hypertension in acromegaly.
• To guide antihypertensive de-escalation based on biochemical control and blood pressure phenotypes.
• To improve the comparability and precision of future acromegaly cohort studies.

Main Methods:

• Utilizing ambulatory and home blood pressure monitoring for standardized phenotyping.
• Classifying sustained, masked, and nocturnal hypertension.
• Incorporating key timepoints: diagnosis, post-therapy reassessment, and long-term follow-up.
• Emphasizing modality-specific diagnostic thresholds and dipping patterns.

Main Results:

• A standardized framework for hypertension phenotyping in acromegaly.
• Clearer classification of sustained, masked, and nocturnal hypertension.
• Guidance for risk-stratified antihypertensive de-escalation.
• Improved precision in assessing cardiovascular risk profiles.

Conclusions:

• Standardized ambulatory and home blood pressure monitoring enables precise phenotyping in acromegaly.
• This approach optimizes antihypertensive treatment decisions and de-escalation strategies.
• Structured follow-up enhances comparability across acromegaly research cohorts.